Literature DB >> 2882502

Effect of circulating somatostatin on exocrine pancreatic secretion in conscious dogs.

E Köhler, C Beglinger, G Ribes, U Grötzinger, M M Loubatiéres-Mariani, K Gyr.   

Abstract

We determined the effects of exogenous somatostatin-14 (100 and 200 ng/kg/h; mimicking postprandial somatostatin concentrations) on pancreatic responses to a background infusion of secretion in combination with graded doses of CCK-8 in conscious dogs with chronic gastric and duodenal fistulas. The lower dose of somatostatin-14 (S-14), which produced S-14 plasma levels lower than measured after a meal, did not change basal or stimulated pancreatic secretion. The upper dose of S-14, which produced plasma S-14 concentrations slightly above the postprandial range, caused inhibition of pancreatic fluid and protein secretion to low doses of CCK-8 (p less than 0.05). The inhibition was surmountable with higher doses of CCK-8. We interpret these data as indicating that circulating S-14 is not an important hormonal regulator of exocrine pancreatic secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2882502     DOI: 10.1097/00006676-198609000-00011

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  1 in total

1.  Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.

Authors:  B M Miller; L W Traverso; P C Freeny; N N Abumrad
Journal:  Int J Pancreatol       Date:  1989-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.